Patchy Hair Loss in a Child With Eczema: Why an Atopy Study Is Not an Individual Prediction
A newly noticed bald patch can be upsetting for a child and parent. Having eczema does not tell you why hair is missing. The useful next step is an assessment of the patch, scalp and hair pattern. Population research can explain why clinicians consider associated conditions, but it cannot identify the cause from a family photograph.
Read the study's denominator before its large ratio
A 2025 Taiwan claims study compared 10,535 young people with atopic diseases with 10,535 controls. Entry ages were 9–18; records covered 1996–2010. The exposed group included eczema, allergic conjunctivitis, asthma, allergic rhinitis or food allergy. It was not an eczema-only group.
| Recorded alopecia areata | Atopic-disease group | Comparison group |
|---|---|---|
| Events | 39 of 10,535 | 11 of 10,535 |
| Reported proportion | 0.37% | 0.10% |
| Adjusted hazard ratio, overall | 9.66 (95% CI 4.18–22.39) | Reference |
The crude proportions and adjusted hazard ratio measure different things; unequal follow-up also matters. The adjusted ratio is not obtained by simply dividing those percentages. Only 50 events, claims-based definitions, residual confounding and one population limit precision and generalizability. This observational result does not prove causation, predict a child's future, or provide an AD-specific effect estimate.
What an alopecia areata patch can look like
NIAMS describes alopecia areata as immune-related hair loss that often begins in round or oval patches. Bare patches usually lack a rash or scarring; nails can sometimes change. The course varies substantially between people. A patch that looks smooth to a parent still needs professional examination rather than diagnosis from a description alone.
Scaly scalp disease, broken hairs or a different distribution raise other questions. Our scalp-ringworm guide addresses a separate cause of patchy loss that should not be mistaken for eczema or assumed to be alopecia areata. Do not share a treatment plan between children because their patches look similar.
What to prepare for the appointment
NIAMS's diagnostic guidance describes examination of hair-loss areas and nails, magnified inspection, and medical and family history. Blood tests or biopsy may be considered when another condition needs to be excluded. Not every child needs every test.
Write down when the patch was first noticed, whether it is expanding, whether the scalp itches or scales, and any changes in eyebrows, eyelashes or nails. Bring a medicine list and mention changes in hairstyles, hair practices or recent illness without assuming one caused the loss. A dated photograph taken with the child's agreement can help document change between visits.
Ask what diagnosis is most likely, what remains uncertain and what would change the plan. If a biopsy is proposed, questions about skin biopsy can help structure the discussion, although scalp procedures need their own instructions.
Protect the child's confidence while the cause is assessed
Let the child choose how much to share with teachers, coaches or friends. Focus a conversation on comfort and support rather than repeated checking of appearance. Eczema's effect on emotional wellbeing is relevant when an additional visible change increases distress.
Avoid promising that a moisturizer, supplement or change in eczema treatment will regrow hair. Neither the cohort nor the cosmetic product discussed below tested that claim. Decisions about alopecia treatment should follow the actual diagnosis, age and extent of hair loss.
If the concern includes generalized thinning and other symptoms rather than a focal patch alone, see how to interpret eczema and thyroid-testing evidence. This is a different question from diagnosing alopecia areata.
A separate role for daily skin comfort
Dr. Arsy Moisturizer #003, 4 oz / 120 g is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. It does not diagnose, treat or prevent eczema or the conditions discussed here. Product choice should follow the actual ingredient label and individual tolerability; adult cosmetic testing does not establish infant or pediatric suitability.
Educational information, not an individual diagnosis or treatment plan. Evidence checked November 9, 2026. The sports image is an AI-created editorial product visual, not a patient photograph or a clinical outcome.